Physician
Rheumatology
Dr. John P. Donohue, MD
|
|
Give Review
John P. Donohue, MD works in the field of Rheumatology. He graduated from Georgetown University School of Medicine. Georgetown University School of Medicine has a rank of 49 in research and a 84 in primary care He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACR)". Doctor John P. Donohue, MD is a published doctor and has 25 publications published. The lastest was: 'A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL 1R1) in patients with osteoarthritis of the knee.' John Donohue accepts Medicare payments and is listed with Medicare.gov.
Publications
- A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL 1R1) in patients with osteoArthritis of the knee.
- Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43.
- Crystal structures of complexes containing domains from two viral internal ribosome entry site (IRES) RNAs bound to the 70S ribosome.
- Aberrant alternative splicing and extraCellular matrix gene expression in mouse models of myotonic dystrophy.
- Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
- Rehabilitation in Ankylosing spondylitis.
- Structural RNAs of known and unknown function identified in malaria parasites by comparative genomics and RNA analysis.
- Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
- Short-term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients.
- Post chemotherapy RPLND in patients with elevated markers: current concepts and clinical outcome.
- Ultraconserved elements are associated with homeostatic control of splicing regulators by alternative splicing and nonsense-mediated decay.
- Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ Cell tumor necessitate adjuvant chemotherapy?
- Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stag...
- Retroperitoneal lymph node dissection in testicular cancer.
- Pathologic findings and therapeutic outcome of desperation post-chemotherapy retroperitoneal lymph node dissection in advanced germ Cell cancer.
- Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ Cell tumors?
- Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
- Impact of the number of positive lymph nodes on Disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor.
- Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer.
- Histology in mixed germ Cell tumors. Is there a favorite pairing?
- Does retroperitoneal lymph node dissection have a curative role for patients with sex cord-stromal testicular tumors?
- Is post-chemotherapy resection of seminomatous elements associated with higher acute morbidity?
- Evolution of retroperitoneal lymphadenectomy (RPLND) in the management of non-seminomatous testicular cancer (NSGCT).
- Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer.
Schools
Georgetown University School Of Medicine
Columbia Presbyterian Med Center
Brigham and Women39s Hospital
Procedures Preformed
- Joint Drainage
- Myofascial Trigger Point Injection
- Steroid Injection
- Trigger Point Injection
- View All
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Adhesive Capsulitis of Shoulder
- Ankle Disorders
- View All
Doctors Specialties
- Rheumatology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACR)
Education
-
Brigham and Women's Hospital -
New York Presbyterian Hospital - Columbia Campus -
Georgetown University School of Medicine
Hospital
-
Cleveland Clinic Florida
Drug Facts
| NPI NUMBER | 1205825387 | |
| NPPES Provider LastName | DONOHUE | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 333313609 | |
| NPPES Provider State | FL | |
| Specialty Description | Rheumatology | |
| Total Claim Count | 2277.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 148.0 | |
| Percent Opioid Claims | 6.5 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1205825387 |
| Last Name Of The Provider | DONOHUE |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Hossam Elzawawy, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Piyush Poddar, MD |